Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
ASP Isotopes Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/03/2023 |
8-K
| Investor presentation|
Docs:
|
"ASP Isotopes Issues Letter to Shareholders. Washington, D.C., October 3, 2023 -- ASP Isotopes Inc. NASDAQ: ASPI , an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann. Dear Fellow Shareholder, At the end of the 3rd quarter, I want to summarize the year-to-date progress and discuss our future goals. We have made significant progress during the first nine months of 2023, completing the construction of our first isotope enrichment plant and signing two supply contracts with North American customers for greater than $11.5 million in expected aggregate revenue for future supply of Carbon-14 and other highly enriched ...",
"Corporate Overview Presentation of ASP Isotopes Inc. dated October 2023" |
|
| 09/28/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/12/2023 |
8-K/A
| Investor presentation |
| 06/12/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/19/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/10/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 04/17/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/05/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/21/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 03/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"COMMON STOCK PURCHASE WARRANT",
"PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT",
"SECURITIES PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"ASP Isotopes Announces $5 Million Private Placement BOCA RATON, FL / ACCESSWIRE / March 15, 2023 / ASP Isotopes Inc. NASDAQ: ASPI , an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 3,164,557 shares of its common stock and warrants to purchase up to an aggregate of 3,164,557 shares of common stock, at a purchase price of $1.58 per share and accompanying warrant in a private placement. The gross proceeds to the Company from the private placement are expected to be approximately $5 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The...",
"ASP Isotopes Announces Closing of $5 Million Private Placement BOCA RATON, FL / ACCESSWIRE / March 17, 2023 / ASP Isotopes Inc. NASDAQ: ASPI , an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, today announced the closing of its previously announced private placement of an aggregate of 3,164,557 shares of its common stock and warrants to purchase up to an aggregate of 3,164,557 shares of common stock, at a purchase price of $1.58 per share and accompanying warrant in a private placement. The gross proceeds to the Company from the private placement were approximately $5 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. H.C. Wainwright & Co. ..." |
|
| 03/14/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/08/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/29/2022 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/16/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/16/2022 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events|
Docs:
|
"ASP Isotopes Inc. UNDERWRITING AGREEMENT",
"ASP Isotopes Inc. Announces Closing of Initial Public Offering and Nasdaq Listing ASP Isotopes Inc. , an advanced materials company dedicated to the development of technology and processes that will allow for the production of isotopes that may be used in several industries, today announced the closing of its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $5.0 million before deducting underwriting discounts, commissions, and other offering expenses. The shares began trading on the Nasdaq Capital Market LLC on November 10, 2022, under the ticker symbol “ASPI.” The Company intends to use the net proceeds of the offering for the completion of its Molybdenum enrichment facility in Pret..." |
|
| 11/09/2022 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 10/18/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 10/11/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 09/12/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
|
|